Antithrombotic drug removal with hemoadsorption during off-pump coronary artery bypass grafting
Abstract Background Patients requiring coronary artery bypass grafting (CABG) are often loaded with antithrombotic drugs (AT) and are at an increased risk for perioperative bleeding complications. Active AT removal by a hemoadsorption cartridge integrated in the cardiopulmonary bypass circuit is inc...
Main Authors: | Helmut Mair, Stephanie Ulrich, Dow Rosenzweig, Johannes Goeppl, Christopher Jurma, Ferdinand Vogt, Benedikt Baumer, Frank Vogel, Peter Lamm |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-04-01
|
Series: | Journal of Cardiothoracic Surgery |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13019-024-02772-1 |
Similar Items
-
A New Apheresis Device for Antithrombotic Drug Removal during Off-Pump Coronary Artery Bypass Surgery
by: Helmut Mair, et al.
Published: (2022-10-01) -
Extracorporeal hemoadsorption therapy as a potential therapeutic option for rapid removal of Apixaban in high risk-surgical patients: a case report
by: Vittorio Dalmastri, et al.
Published: (2023-07-01) -
Post VV-ECMO Weaning Hyperinflammation—Can Prophylactic Hemoadsorption Treatment Prevent Complications?
by: Pedja Kovacevic, et al.
Published: (2023-10-01) -
Intraoperative ticagrelor removal via hemoadsorption during on-pump coronary artery bypass graftingCentral MessagePerspective
by: Kambiz Hassan, MD, et al.
Published: (2023-09-01) -
Use of CytoSorb® hemoadsorption column during prolonged cardiopulmonary bypass in complex cardiac surgery patient
by: Marianne Alarie, et al.
Published: (2022-07-01)